A group of UF researchers will use a new $3.3 million grant to evaluate safety, tolerability, and general response to the probiotic Lactobacillus johnsonii N6.2 in people with T1D. The scientists aim to determine if the probiotic has a positive impact on gastrointestinal health and general wellness for individuals with T1D.
Join us in celebration of World Diabetes Day on the UF campus on 11/14! Click to learn about our scheduled events.
The UFDI director was awarded the 2019 Jacobæus Prize, one of the top international honors in the field of endocrinology & metabolism, for contributions to groundbreaking T1D research.
All for ONE is seeking two female UF students with T1D to serve as mentors for teenagers with T1D. Email Xanadu Roque at firstname.lastname@example.org for more information.
We are now accepting abstracts for our World Diabetes Day Poster Session on Nov. 14th from 9:30-11:00 am in the HPNP Reception Hall.
Ashby Walker, Ph.D., director for health equity initiatives at the UF Diabetes Institute, was named as one of Diabetes Forecast Magazine's People to Know 2019! Dr. Walker was recognized for the Directed Research in Type 1 Diabetes class she developed for University of Florida students who have a personal connection to type 1 diabetes.
Applications opened on August 20th and will close on September 5th at midnight.
A group of University of Florida researchers will use a new $5 million grant to develop a “pancreatic islet on a chip”— a platform that will allow them to more efficiently and effectively study Type 1 diabetes and potential treatments for the condition.
University of Florida Health Shands Hospital ranks among the nation’s elite in seven adult medical specialties in U.S. News & World Report’s 2019-20 “Best Hospitals” report released today.